Trial updateRetina
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Recruiting. Phase 2. Registered enrolment: 272. Novartis Pharmaceuticals
Why it matters
Track this study through NCT07441642. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 2
- Registered enrolment
- 272
- Results posted
- No
- Sponsor
- Novartis Pharmaceuticals
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 9 Sept 2026 · United States · Australia · Bulgaria · Canada · Colombia · Czechia · France · Germany · Hungary · Italy · Japan · Poland · Puerto Rico · Romania · Spain · United Kingdom